Comet Therapeutics - About the company
Comet Therapeutics is an acqui-hired company based in Cambridge (United States), founded in 2017 by . It operates as a Developer of enzyme substitution therapy for neurological diseases. Comet Therapeutics has raised $28.5M in funding from investors like Sofinnova Partners, Canaan and Inkef. The company has 111 active competitors, including 43 funded and 37 that have exited. Its top competitors include companies like Alnylam, Ultragenyx and BioMarin Pharmaceutical.
Company Details
Comet Therapeutics is a developer of enzyme substitution therapy for neurological diseases. It focused on the treatment of orphan neurological disorders through Coenzyme-A substitution therapy. It has developed a CoEnzyme metabolism (CoMET) platform to restore dysregulated CoEnzyme A metabolism.
- Website
- Social
Key Metrics
Founded Year
2017
Location
Cambridge, United States
Stage
Acqui-Hired
Total Funding
in 2 rounds
Latest Funding Round
Investors
Ranked
70th among 111 active competitors
Similar Companies
Alnylam &
Comet Therapeutics's funding and investors
Comet Therapeutics has raised a total funding of $28.5M over 2 rounds. Its latest funding round was a Series A round on Jun 19, 2019 for $28.5M. 4 investors participated in its latest round, which includes Canaan, Sofinnova Partners, Inkef and Mission BioCapital.
Comet Therapeutics has 4 institutional investors including Sofinnova Partners, Canaan and Inkef.
Here is the list of recent funding rounds of Comet Therapeutics:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Jun 19, 2019 | $28.5M | Series A | 4329415 | 6290669 | Mission BioCapital, Canaan, and |
Access funding benchmarks and valuations. Sign up today!View details of Comet Therapeutics's funding rounds and investors
Comet Therapeutics's founders and board of directors
The founders of Comet Therapeutics is .
View details of Comet Therapeutics's Founder profiles and Board Members
Comet Therapeutics's Competitors and alternates
Top competitors of Comet Therapeutics include Alnylam, Ultragenyx and BioMarin Pharmaceutical. Here is the list of Top 10 competitors of Comet Therapeutics, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Alnylam 2002, Cambridge (United States), Public | Developer of RNA interference-based therapeutics for multiple disorders | $17M | Ridgeback Capital Management, AbingworthÌý&²¹³¾±è;Ìý | 78/100 |
2nd | Ultragenyx 2010, Novato (United States), Acquired | Developer of therapeutics for the treatment of rare and ultra-rare metabolic diseases | $135M | TPG, Adage Capital ManagementÌý&²¹³¾±è;Ìý | 75/100 |
3rd | BioMarin Pharmaceutical 1997, San Rafael (United States), Public | Developer of therapeutics for the treatment of rare genetic diseases | $36M | Tekla Capital Management, Ridgeback Capital ManagementÌý&²¹³¾±è;Ìý | 72/100 |
4th |  Mirum Pharmaceuticals 2018, Menlo Park (United States), Public | Developer of small molecule based therapeutics to treat rare diseases | $120M | Frazier Healthcare Partners, New Enterprise AssociatesÌý&²¹³¾±è;Ìý | 68/100 |
5th | Homology Medicines 2015, Lexington (United States), Acquired | Developer of gene therapies for rare genetic diseases | $127M | Vivo Capital, DeerfieldÌý&²¹³¾±è;Ìý | 68/100 |
6th | Pharvaris 2015, Leiden (Netherlands), Public | Orally deliverable bradykinin B2 antagonists for hereditary angioedema | $164M | Venrock, Foresite CapitalÌý&²¹³¾±è;Ìý | 67/100 |
7th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | Hercules Capital, Ridgeback Capital ManagementÌý&²¹³¾±è;Ìý | 66/100 |
8th | ProQR Therapeutics 2012, Leiden (Netherlands), Public | Developer of RNA-based therapeutics for the treatment of genetic disorders such as inherited retinal disorders | $58M | Foresite Capital, Kreos CapitalÌý&²¹³¾±è;Ìý | 66/100 |
9th | Immusoft 2009, Seattle (United States), Series B | Autologous cell therapies based on its Immune system programming technology to treat variety of diseases. | $44.1M | Founders Fund, NIHÌý&²¹³¾±è;Ìý | 65/100 |
10th | American Gene 2008, Rockville (United States), Series B | Developer of lentivirus therapies for the treatment of cancer and other chronic human diseases | $52.8M | NIH, Alumni VenturesÌý&²¹³¾±è;Ìý | 64/100 |
70th |  Comet Therapeutics 2017, Cambridge (United States), Acqui-Hired | Developer of enzyme substitution therapy for neurological diseases | $28.5M | Canaan, Sofinnova PartnersÌý&²¹³¾±è;Ìý | 27/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Comet Therapeutics's competitors? Click to see the top ones
Comet Therapeutics's Investments and acquisitions
Comet Therapeutics has made no investments or acquisitions yet.
Reports related to Comet Therapeutics
Here is the latest report on Comet Therapeutics's sector:
View
News related to Comet Therapeutics
•
•
Sofinnova Partners•Jun 19, 2019•Comet Therapeutics, Sofinnova Partners, Inkef Capital, Mission BioCapital and 1 other
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Comet Therapeutics
When was Comet Therapeutics founded?
Comet Therapeutics was founded in 2017.Where is Comet Therapeutics located?
Comet Therapeutics is located in Cambridge, United States.When was the latest funding round of Comet Therapeutics?
Comet Therapeutics's latest funding round was on Jun 19, 2019.What is the annual revenue of Comet Therapeutics?
Annual revenue of Comet Therapeutics is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Korean Shop Serbia - Belgrade based, 2024 founded, Unfunded company
- TUITO - La Ciotat based, 2017 founded, Unfunded company
- Faasinihe - Parnu based, 2010 founded, Unfunded company
- Thai Nguyen University of Economics and Business Administration - Thai Nguyen based, 2004 founded, Funding Raised company
- Anismak - Ankara based, 1984 founded, Unfunded company
- SD Bygg & Ventilasjon - Eidsberg based, 2012 founded, Unfunded company
